<table border="1" id="ia28a3d41-99d4-4c75-8494-1a38804b482f" width="812" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 1:  Comparisons of the Systemic Availability and Equivalent Doses for Preparations of Digoxin</caption>
<tbody>
<tr>
<td>PRODUCT</td>
<td>ABSOLUTE BIOAVAILABILITY</td>
<td>
<paragraph>EQUIVALENT DOSES (mcg)*</paragraph>
<paragraph>AMONG DOSAGE FORMS</paragraph>
</td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr>
<td>Digoxin Tablets</td>
<td>60-80%</td>
<td>62.5</td>
<td>125</td>
<td>250</td>
<td>500</td>
</tr>
<tr>
<td>Digoxin Elixir Pediatric</td>
<td>70-85%</td>
<td>62.5</td>
<td>125</td>
<td>250</td>
<td>500</td>
</tr>
<tr>
<td>Digoxin Capsules</td>
<td>90-100%</td>
<td>50</td>
<td>100</td>
<td>200</td>
<td>400</td>
</tr>
<tr>
<td>Digoxin Injection/IV</td>
<td>100%</td>
<td>
<paragraph>50</paragraph>
<paragraph></paragraph>
</td>
<td>100</td>
<td>200</td>
<td>400</td>
</tr>
</tbody>
</table>